Pancreatic Cancer Research

ResearcherFirst Affiliated Hospital of Xi'an Jiaotong UniversityNo recent work listed

Yi Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5482-0093; OpenAlex author ID A5100330547. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: 1 paper · 2022: 1 paper

Papers 3

  1. A TP53-associated immune prognostic signature for the prediction of the overall survival and therapeutic responses in pancreatic cancer. Co-author DOI 10.3934/mbe.2022010↗
  2. Three Immune-Related Prognostic mRNAs as Therapeutic Targets for Pancreatic Cancer. Co-author DOI 10.3389/fmed.2021.649326↗
  3. Bioinformatics profiling utilized a nine immune-related long noncoding RNA signature as a prognostic target for pancreatic cancer. Co-author DOI 10.1002/jcb.28754↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Lei Wang · 1 shared paper, 2022 · strength 0.19
  2. Cangang Zhang · 1 shared paper, 2021 · strength 0.14
  3. Haibo Liu · 1 shared paper, 2021 · strength 0.14
  4. Chunmi Wei · 1 shared paper, 2019 · strength 0.10
  5. Jianjun Li · 1 shared paper, 2019 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.